BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15950806)

  • 1. Treatment planning system evaluation for mesothelioma IMRT.
    Stevens CW; Wong PF; Rice D; Jeter M; Forster K; Zhu XR
    Lung Cancer; 2005 Jul; 49 Suppl 1():S75-81. PubMed ID: 15950806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate surface brachytherapy to boost elongated, curvilinear incisional scars after extrapleural pneumonectomy for malignant pleural mesothelioma treated with adjuvant intensity-modulated radiation therapy.
    Doyle LA; Showalter TN; Werner-Wasik M; Weksler B; Xiao Y; Yu Y; Macrone A; Liu H; Harrison A
    Brachytherapy; 2010; 9(1):86-90. PubMed ID: 19846346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiation therapy for mesothelioma: impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency.
    Zhu XR; Prado K; Liu HH; Guerrero TM; Jeter M; Liao Z; Rice D; Forster K; Stevens CW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1525-34. PubMed ID: 16029815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma.
    Allen AM; Schofield D; Hacker F; Court LE; Czerminska M
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1587-92. PubMed ID: 17892915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
    Miles EF; Larrier NA; Kelsey CR; Hubbs JL; Ma J; Yoo S; Marks LB
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1143-50. PubMed ID: 18262369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy.
    Javedan K; Stevens CW; Forster KM
    J Appl Clin Med Phys; 2008 Oct; 9(4):98-109. PubMed ID: 19020484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RapidArc volumetric modulated therapy planning for prostate cancer patients.
    Kjaer-Kristoffersen F; Ohlhues L; Medin J; Korreman S
    Acta Oncol; 2009; 48(2):227-32. PubMed ID: 18855157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte Carlo approaches.
    Jang SY; Liu HH; Wang X; Vassiliev ON; Siebers JV; Dong L; Mohan R
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):939-48. PubMed ID: 17011466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer.
    Chung HT; Lee B; Park E; Lu JJ; Xia P
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1167-74. PubMed ID: 18234440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMRT quality assurance using a second treatment planning system.
    Anjum MN; Parker W; Ruo R; Aldahlawi I; Afzal M
    Med Dosim; 2010; 35(4):274-9. PubMed ID: 19944590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lens dose in MLC-based IMRT treatments of the head and neck.
    Pawlicki T; Luxton G; Le QT; Findley D; Ma CM
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):293-9. PubMed ID: 15093926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.